Biotech Company Adding Jobs in Lafayette
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowA Maryland-based life sciences company is expanding its Lafayette facility. ACell Inc. plans to add 50 jobs as part of the project. The company specializes in medicine to repair and remodel damaged tissue. October 25, 2013
News Release
Lafayette, Ind. – October 25, 2013 – An announcement Friday by ACell Inc. that it will expand its Lafayette operations in Duncan Park drew applause and enthusiasm from government and economic development officials.
The expansion includes $6 million in equipment, 50 new jobs on top of today’s current employment of 70, and 14,000 square feet of new space, bringing its facility size to 42,000 square feet by spring.
Duncan Park developer, INOK Investments LLC, is spending another $3 million to construct the ACell addition and a new stand-alone building in the 79-acre park.
“Today’s announcement is akin to opening one gift after another, each one more spectacular,” said Lafayette mayor Tony Roswarski. “First, we have the facility investment by INOK Investments LLC. Next we have an announcement that a young company will keep growing here—and it’s not only a business with huge potential, it’s a next-generation science business that is successfully pioneering advances in the medical world. Its products heal wounds, restore function and improve human lives.”
Jody Hamilton, economic development director for Greater Lafayette Commerce, which worked with the company, said, “This is a leading-edge company that is making giant strides. It’s growing, growing here, and rapidly gaining recognition in the medical world for its products. ACell’s news today is quite a milestone, for the company and for our community.”
ACell Inc. was founded in 1999 by physician Alan Spievack, who has since died, and is headquartered in Columbia, Maryland. The private company develops and manufactures regenerative medicine products that are used to repair and remodel damaged tissue.
It opened its Lafayette operations, the company’s only other site, in May 2006, in a 2,500 square-foot-facility in Duncan Park, and has increased its space a couple of times since.
“The saying, ‘If you build it, they will come,’ is indeed true here in Lafayette,” said Jerry Brand of INOK Investments LLC. “What we are building in this community is a positive business climate, an exemplary quality of life, and attractive commercial and industrial sites. Add in our educated, dedicated workforce, and we have companies like ACell saying ‘yes’ to Lafayette.”
“ACell is the kind of company that every community would like to have,” Roswarski said. “This is a company with a solid business plan, a determination to grow and a commitment to introducing and supplying breakthrough medical products that were only dreamed of a few years ago.”
About Greater Lafayette Commerce. Headquartered at 337 Columbia St. in Lafayette, Greater Lafayette Commerce (www.greaterlafayettecommerce.com), whose roots go back more than 85 years, is a nonprofit membership organization supported by local businesses, industries and governments. Its mission is to advance economic and community prosperity for a superior quality of life.Source: Greater Lafayette Commerce
News Release
Columbia, MD – (October 25, 2013) – ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has broken ground on a the expansion of its manufacturing facility in Lafayette, Indiana to support the Company’s current and anticipated growth.
The 14,000 square-foot addition to the current building will increase scalability and efficiency of ACell’s day-to-day operations and is expected to be completed in late 2014. With the expansion, the total manufacturing space will exceed 42,000 square feet.
“The significant growth of our business driven by continued physician adoption of MatriStem has driven us to expand capacity our Lafayette facility by roughly 50%,” said Rodney Bosley, ACell President and Chief Operating Officer. “Our Indiana facility is currently capable of producing all of our 510(k) cleared products from raw material processing through final packaging. This expansion will provide us with additional end-to-end manufacturing capabilities that we believe will support our growth for several years to come.”
ACell manufactures its MatriStem products in facilities located in Lafayette, Indiana and Columbia, Maryland using a complex and highly specialized process, requiring precision and expertise to address various technical, engineering and regulatory challenges. The Lafayette facility processes all of the material used in MatriStem products and manufactures the majority of ACell’s products.
“As an integral part of the Lafayette community, ACell offers an opportunity to help stimulate the local economy, and we are proud to support the Company as they expand their facility with the goal of transforming the standard of medical care and improving the quality of life of patients who are treated with their devices,” said City of Lafayette Mayor Tony Roswarski.
ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures. For more information, visit www.acell.com.
About ACell, Inc. ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products. Its medical devices are cleared for a variety of indications and are marketed under the brand name “MatriStem.” A privately held company, ACell produces MatriStem at its full scale manufacturing facilities in Columbia, MD and Lafayette, IN, and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.
About MatriStem® MatriStem Products are porcine-derived extracellular matrix (ECM), essential structures that maintain and support a healing environment through constructive tissue remodeling. MatriStem contains the basement membrane of porcine urinary bladder tissue, or urinary bladder matrix (UBM). UBM is a layer of tissue that is a critical component of constructive tissue remodeling. It provides MatriStem with several distinguishable characteristics, including the ability to facilitate the body’s own regenerative capabilities and help restore normal site-appropriate tissue while avoiding scar tissue formation; the ability to be used “off-the-shelf” and stored at room temperature, with an approximate two year shelf life; and superior ease-of-use characteristics. MatriStem products are indicated for use in a wide range of regenerative and tissue repair applications and come in a range of sizes and thicknesses. It is the only ECM of its kind available in powder form. It has been cleared for use in general surgery, gynecological surgery and a wide range of wounds, including diabetic foot ulcers (DFU), venous leg ulcers (VLU), pressure, surgical, and tunneled wounds. Refer to IFU supplied with each device for indications, contraindications, and precautions. All MatriStem devices are made in the USA. Source: ACell Inc.